Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 0.26%, near the low end of its 5-year range (0.00%–9.08%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 0.05%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
0.05%
DEBT TO ASSETS RATIO AVG 3Y
0.04%
DEBT TO ASSETS RATIO AVG 5Y
0.26%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 808 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Estrella Immunopharma, Inc.
Market Cap
$17.61M
Debt to Assets Ratio
0.00%
TTM Avg
0.05%
3Y Avg
0.04%
5Y Avg
0.26%
Market Cap
$17.14M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$17.01M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.71M
Debt to Assets Ratio
0.53%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$18.65M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$16.52M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $17.61M | 0.00% | 0.05% | 0.04% | 0.26% |
| Cosmos Health Inc. (COSM)vs › | $17.81M | 0.26% | N/A | N/A | N/A |
| PAVmed Inc. (PAVM)vs › | $17.30M | 0.42% | N/A | N/A | N/A |
| Lipocine Inc. (LPCN)vs › | $17.19M | 0.00% | N/A | N/A | N/A |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | 0.03% | N/A | N/A | N/A |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 0.00% | N/A | N/A | N/A |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.71M | 0.53% | N/A | N/A | N/A |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | 0.00% | N/A | N/A | N/A |
| Bionano Genomics, Inc. (BNGO)vs › | $16.52M | 0.14% | N/A | N/A | N/A |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | 0.77% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
N/A
Current Ratio
0.20
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.11% |
| 2025-06-30 | 0.13% |
| 2025-03-31 | 0.41% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.13% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 1.10% |
| 2023-06-30 | 9.08% |
| 2023-03-31 | 7.28% |
| 2022-12-31 | 1.64% |
| 2022-09-30 | 1.09% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 5.23% |
| 2021-02-28 | 39.34% |
